Home › Calculator › KPTI Dividend Calculator 2026
KPTI Dividend DRIP Calculator 2026
111.73% YieldHealthcareKaryopharm Therapeutics Inc. · NASDAQ
Price: $1.79 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When KPTI pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your KPTI snowball 📈
$10,000 in KPTI → $1420794769.34M in 10 years · $117,822,907,573,111.30/month
About Karyopharm Therapeutics Inc. (KPTI) — Dividend Analysis 2026
Karyopharm Therapeutics Inc. is a pharmaceutical company that has already brought products to market, focusing on identifying, advancing, and selling medications designed to disrupt nuclear export pathways. These drugs are primarily aimed at treating cancer and various other illnesses. The company's strategy involves researching, creating, and marketing innovative Selective Inhibitor of Nuclear Export (SINE) compounds, which operate by attaching to and deactivating the nuclear export protein XPO1. Their leading therapeutic, XPOVIO, holds approvals for several critical applications in adult patients: it is prescribed in combination with bortezomib and dexamethasone for multiple myeloma; alongside dexamethasone for those with heavily pretreated multiple myeloma; and as a standalone treatment for relapsed or refractory diffuse large B-cell lymphoma. Karyopharm has also established a licensing partnership with the Menarini Group, granting them rights to develop and market NEXPOVIO for human oncology indications across Europe (including the United Kingdom), Latin America, and other global regions. Furthermore, the company's oral SINE compounds are specifically engineered to promote the accumulation of various tumor suppressor and growth-regulating proteins within the cell nucleus. Established in 2008, Karyopharm Therapeutics Inc. maintains its principal offices in Newton, Massachusetts.
Compare KPTI with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full KPTI DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open KPTI position with:
🌍 KPTI Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold KPTI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 111.73% | 108.93% | $11,173 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 94.97% | 92.17% | $9,497 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 89.38% | 86.58% | $8,938 / yr |
| 🇬🇧 UK ISA | 0% | 111.73% | 108.93% | $11,173 / yr |
| 🇬🇧 UK Taxable | 8.75% | 101.95% | 99.15% | $10,195 / yr |
| 🇨🇦 TFSA | 0% | 111.73% | 108.93% | $11,173 / yr |
| 🇨🇦 CA Taxable | 25% | 83.80% | 81.00% | $8,380 / yr |
| 🇦🇺 Super (pension) | 15% | 94.97% | 92.17% | $9,497 / yr |
| 🇦🇺 AU Taxable | 30% | 78.21% | 75.41% | $7,821 / yr |
| 🇩🇪 DE Taxable | 26.375% | 82.26% | 79.46% | $8,226 / yr |
| 🇫🇷 FR Taxable | 30% | 78.21% | 75.41% | $7,821 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 KPTI Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 KPTI Dividend Payment Schedule
KPTI pays quarterly — 4 times per year. Next ex-div: TBD.
📊 KPTI vs Healthcare Benchmarks
How KPTI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for KPTI sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ KPTI Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-09-01 | 19 | $2.02 | $38.00 | ||
| Sale | 2026-07-28 | 189 | $7.10 | $1.3K | ||
| A-Award | 2026-05-21 | 15,508 | — | — | ||
| A-Award | 2026-05-21 | 15,508 | — | — | ||
| A-Award | 2026-05-21 | 15,508 | — | — | ||
| A-Award | 2026-05-21 | 15,508 | — | — | ||
| A-Award | 2026-05-21 | 15,508 | — | — | ||
| A-Award | 2026-05-21 | 15,508 | — | — | ||
| A-Award | 2026-05-13 | 896 | — | — | ||
| Sale | 2026-05-14 | 403 | $9.50 | $3.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where KPTI earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the KPTI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Karyopharm Therapeutics Inc. (KPTI) is currently trading at $1.79, trading near its 52-week low. The current dividend yield is 111.73% based on an annual payout of $2.00 per share.
KPTI (Karyopharm Therapeutics Inc.) — 111.73% Dividend Yield Analysis
Karyopharm Therapeutics Inc. (KPTI) is a healthcare stock currently trading at $1.79 with a dividend yield of 111.73%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (111.73%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest KPTI News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.